Article info

Use of Janus kinase inhibitors in COVID-19: a prospective observational series in 522 individuals

Authors

  1. Correspondence to Dr Oleg Melikhov, Institut kliniceskih issledovanij OOO, Moskva 119590, Russian Federation; melikhov.oleg{at}gmail.com
View Full Text

Citation

Melikhov O, Kruglova T, Lytkina K, et al
Use of Janus kinase inhibitors in COVID-19: a prospective observational series in 522 individuals

Publication history

  • Received February 1, 2021
  • Accepted May 25, 2021
  • First published June 7, 2021.
  • Supplementary Data

    This web only file has been produced by the BMJ Publishing Group from an electronic file supplied by the author(s) and has not been edited for content.

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.